insights_auto
Why is YP2 down 7,94%?
Dive Deeperchevron_right
YP2:FRA
BioLine RX Ltd - ADR
1,16 €
arrow_downward
-7,94%(-0,10) 1D
13 қар., 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for YP2...
Open
0,97 €
High
1,16 €
Low
0,97 €
Mkt. cap
9,30 млн
Avg. vol.
50,00
Volume
0,00
52-wk high
3,26 €
52-wk low
0,97 €
No. of employees
22
Open
0,97 €
High
1,16 €
Low
0,97 €
Mkt. cap
9,30 млн
Avg. vol.
50,00
Volume
0,00
52-wk high
3,26 €
52-wk low
0,97 €
No. of employees
22
News stories
From web sources and news partners
The Motley Fool
·
21 минут бұрын
History Says Every S&P 500 Bear Market Has Ended the Same Way. Here's the Pattern.
TradingKey
·
9 сағат бұрын
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
16 сағат бұрын
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
Traders Union
·
1 сағат бұрын
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees22
Founded2003
Headquarters-
SectorHealth Care
Industry-
Websitebiolinerx.com